BioTech Medics, Inc. Enters Into SHBAN(TM) Hand Sanitizer Dubai Distribution Agreement
30 September 2009 - 12:23AM
Marketwired
BioTech Medics, Inc. (PINKSHEETS: BMCS) announced today that they
have entered into a wholesaler Distribution Agreement for BioTech's
patented and exclusive SHBAN(TM) Antimicrobial Hand Sanitizer
Products with a Dubai distributor.
The initial income and fees to BioTech for 2009 for the Dubai
Distributorship is $58,800 (US) and projected $2,000,000 (US) in
sales for 2010.
SHBAN is manufactured at an FDA registered plant. It is a
bio-degradable product superior to most anti-bacterial hand
sanitizers because 1) SHBAN is longer lasting, SHBAN does NOT
contain alcohol gel which has poisoned over 22,000 children in the
USA after application; 2) SHBAN is non-toxic when used as directed
on humans; 3) SHBAN is non-staining; 4) SHBAN is non-flammable; and
5) SHBAN contains no ammonia, nor bleach, nor Benzalkonium Chloride
(BOC), nor Triclosan®, nor thymus vulgaris (which is a potent
carcinogen for rodents) nor fragrance, or other lotion ingredients.
Most hand sanitizer products cannot make all of these claims.
SHBAN is protected under US Letters of Patent #5,514,808,
#5,574,050, #5,679,711 and #5,585,391 and a patent pending for the
US and international patent. SHBAN is a trademark of BioTech
Medics, Inc. BioTech is seeking and negotiating USA and foreign
distributorships at this time and will be announcing more foreign
distributorships soon.
SHBAN(TM) in previous in vitro and in vivo testing has been
evaluated for its antimicrobial properties against Staph. Aureus,
Staph. Epidermidis, EC. Faecalis, E. Coli and Ps. Aeruginosa. Prior
research and clinical studies have been conducted at the University
of TX Medical Branch, Galveston, TX; Microbiology & Biochemical
Assay Laboratories - Houston, Texas; Pathology Associates,
Pasadena, Texas; Texas A & M University - College of Veterinary
Medicine, College Station, Texas; Baylor College of Dentistry,
Dallas, TX; Allergan, Irvine, CA; Culleen Eye Institute, Baylor
College of Medicine, Houston, Texas.
BioTech has recently commenced independent clinical testing of
SHBAN(TM) Hand Sanitizer Solution to determine if it reduces (or
kills) the H1N1 (Swine) Influenza A virus.
Interested parties desiring a SHBAN Distributorship should
contact BioTech immediately.
Safe Harbor: Forward-Looking Statements
This release contains forward-looking statements within the
meaning of The Private Securities Litigation Reform Act of 1995
(the "Act"). The statements above have not been evaluated by the
FDA. SHBAN is not intended to diagnose, treat or cure any
disease.
Add to Digg Bookmark with del.icio.us Add to Newsvine
Contact: Tom Wood Sr. V.P. Sales Phone 972-849-3782
BioTech Medics (PK) (USOTC:BMCS)
Historical Stock Chart
From Jun 2024 to Jul 2024
BioTech Medics (PK) (USOTC:BMCS)
Historical Stock Chart
From Jul 2023 to Jul 2024